Ontology highlight
ABSTRACT: Objective
Allopurinol dosing has frequently been limited based on creatinine clearance (CrCL), resulting in failure to achieve target serum urate (SU). The aim of this analysis was to determine how many milligrams of allopurinol above the recommended CrCL-based dose (R+) are required to achieve target SU and to investigate the factors that influence R+.Methods
We analysed data from participants in a 24-month open, randomized, controlled, parallel-group, comparative clinical trial. Data obtained during the 12-month dose escalation (DE) phase of the study (year 1 for DE/DE and year 2 for control/DE) were combined. R+ dose was defined as the number of milligrams of allopurinol above the CrCL-based dose at the final visit.Results
Of the 132 participants, R+ allopurinol
SUBMITTER: Stamp LK
PROVIDER: S-EPMC6240322 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature